S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563. On page 554, the sentence "Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treat...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-09-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/corrigendum-s-nitroso-n-acetylcysteine-attenuates-liver-fibrosis--a14329 |
| _version_ | 1819064927606800384 |
|---|---|
| author | Mazo DF de Oliveira MG Pereira IV Cogliati B Stefano JT de Souza GF Rabelo F Lima FR Ferreira Alves VA Carrilho FJ de Oliveira CP |
| author_facet | Mazo DF de Oliveira MG Pereira IV Cogliati B Stefano JT de Souza GF Rabelo F Lima FR Ferreira Alves VA Carrilho FJ de Oliveira CP |
| author_sort | Mazo DF |
| collection | DOAJ |
| description | Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563. On page 554, the sentence "Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treating fibrosis..." contains an error. The term "antifibrinogenic" should be replaced by "antifibrogenic". On page 558, Figure 3 (D), the intermediate block corresponding to SNAC is missing. View original paper by Mazo et al |
| first_indexed | 2024-12-21T15:38:21Z |
| format | Article |
| id | doaj.art-2a79ddc8e0d5471aad6b3c703f0d2b8d |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-12-21T15:38:21Z |
| publishDate | 2013-09-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-2a79ddc8e0d5471aad6b3c703f0d2b8d2022-12-21T18:58:35ZengDove Medical PressDrug Design, Development and Therapy1177-88812013-09-012013default971972S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]Mazo DFde Oliveira MGPereira IVCogliati BStefano JTde Souza GFRabelo FLima FRFerreira Alves VACarrilho FJde Oliveira CPMazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ, de Oliveira CP. Drug Des Devel Ther. 2013:7:553–563. On page 554, the sentence "Therefore, we chose SNAC as a potential antifibrinogenic NO donor drug for treating fibrosis..." contains an error. The term "antifibrinogenic" should be replaced by "antifibrogenic". On page 558, Figure 3 (D), the intermediate block corresponding to SNAC is missing. View original paper by Mazo et alhttp://www.dovepress.com/corrigendum-s-nitroso-n-acetylcysteine-attenuates-liver-fibrosis--a14329 |
| spellingShingle | Mazo DF de Oliveira MG Pereira IV Cogliati B Stefano JT de Souza GF Rabelo F Lima FR Ferreira Alves VA Carrilho FJ de Oliveira CP S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] Drug Design, Development and Therapy |
| title | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] |
| title_full | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] |
| title_fullStr | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] |
| title_full_unstemmed | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] |
| title_short | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum] |
| title_sort | s nitroso n acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis corrigendum |
| url | http://www.dovepress.com/corrigendum-s-nitroso-n-acetylcysteine-attenuates-liver-fibrosis--a14329 |
| work_keys_str_mv | AT mazodf snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT deoliveiramg snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT pereiraiv snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT cogliatib snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT stefanojt snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT desouzagf snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT rabelof snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT limafr snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT ferreiraalvesva snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT carrilhofj snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum AT deoliveiracp snitrosonacetylcysteineattenuatesliverfibrosisinexperimentalnonalcoholicsteatohepatitiscorrigendum |